Thursday, April 3, 2025
HomeTagsImmune cells

immune cells

Orna Therapeutics Appoints Joseph Bolen, Ph.D., as Chief Executive Officer

Orna Therapeutics, a biotechnology company dedicated to engineering immune cells in vivo to treat oncology and autoimmune diseases, announced the appointment of Joseph Bolen, Ph.D., as...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics